NT_1170x120_1-11-18

William Shrank

CVS Specialty Connect elevates adherence

WOONSOCKET, R.I. — New research published by the CVS Health Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect, CVS Health’s specialty prescription services program. New patients enrolled in the pilot were 17.5% more likely to pick up their first refill, and existing

CVS Specialty Connect sees improved Rx adherence

CVS Specialty Connect sees improved Rx adherence

WOONSOCKET, R.I. — CVS Health found that patients in a pilot study of its Specialty Connect specialty drug program had a significant improvement in adherence to their medication. CVS said Friday that new patients enrolled in the pilot were 17.5% more likely to pick up their first refill, and current specialty patients had an 11.4

CVS boosts digital Rx functionality with new tools

CVS boosts digital Rx functionality with new tools

WOONSOCKET, R.I. — CVS Health has unveiled a suite of digital tools designed to help customers better manage and adhere to their prescriptions. The company said Wednesday that the five new digital health tools — Apple Watch app integration, Scan Paper Script, Insurance Card Scan, MedRemind and in-store pharmacy messages — were developed to address

Health care partnerships are wave of the future

Health care partnerships are wave of the future

The move toward closer cooperation among providers is one of the more intriguing developments in health care, one that promises to improve patient outcomes and limit expenditures in a sector that accounts for almost 20% of the nation’s gross domestic product. The rationale behind the partnerships, and the role of community pharmacies within them, is

Study: Narrow networks can raise adherence rates

WOONSOCKET, R.I. — A CVS Health Research Institute review of pharmacy claims for more than 200,000 patients found an association between narrow pharmacy networks and improved medication ­adherence. The study was the first to evaluate the impact of narrow pharmacy networks — which incentivize plan members to use in-network pharmacies — on medication adherence. Such

CVS Health: Initial Rx fills offer adherence clues

CVS Health: Initial Rx fills offer adherence clues

WOONSOCKET, R.I. — The first prescriptions filled by patients with chronic conditions provide a good sign of how well they will adhere to their medications, according to research by CVS Health. CVS said Monday that a new study by the CVS Health Research Institute and Brigham and Women’s Hospital revealed that patients’ patterns of medication

CVS study: Narrow networks aid Rx adherence

CVS study: Narrow networks aid Rx adherence

WOONSOCKET, R.I. — Members of drug benefit plans with narrow pharmacy networks show improved medication adherence, according to a new study by the CVS Health Research Institute. CVS Health said Tuesday that the research, published in JAMA Internal Medicine, is the first to gauge the impact of narrow pharmacy networks on medication adherence. Narrow networks

CVS researchers re-examine cholesterol treatments

WOONSOCKET, R.I. — CVS Health Research Institute experts have urged cardiologists to consider changing their treatment guidelines for patients with high cholesterol as a new class of high-cost medications arrives on the market. A commentary published online in the Journal of the American Medical Association on August 10 argued that the new cholesterol-lowering drugs, known

CVS: Patients give high marks to telehealth

CVS: Patients give high marks to telehealth

WOONSOCKET, R.I. — Retail clinic patients find the telehealth experience very satisfying, according to a CVS Health Research Institute study of a pilot program at MinuteClinic. CVS said Tuesday that satisfaction with quality of care and other factors were measured among patients participating in a telehealth technology pilot conducted at MinuteClinic locations in California and

CVS Health: Rx therapy for high cholesterol needs review

CVS Health: Rx therapy for high cholesterol needs review

WOONSOCKET, R.I. — The cardiology community should review and reconsider current treatment guidelines for the management of high cholesterol, according to experts at the CVS Health Research Institute. In a commentary published online Monday in the Journal of the American Medical Association (JAMA), the CVS Health experts said that as PCSK9 inhibitors — a new